The latest price target for Teladoc Health (NYSE:TDOC) was reported by Citigroup on May 5, 2026. The analyst firm set a price target for $7.00 expecting TDOC to fall to within 12 months (a possible -16.37% downside). 24 analyst firms have reported ratings in the last year.

The latest analyst rating for Teladoc Health (NYSE:TDOC) was provided by Citigroup, and Teladoc Health maintained their neutral rating.

The last upgrade for Teladoc Health Inc happened on March 10, 2026 when Deutsche Bank raised their price target to $11. Deutsche Bank previously had a hold for Teladoc Health Inc.

There is no last downgrade for Teladoc Health.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Teladoc Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Teladoc Health was filed on May 5, 2026 so you should expect the next rating to be made available sometime around May 5, 2027.

While ratings are subjective and will change, the latest Teladoc Health (TDOC) rating was a maintained with a price target of $6.00 to $7.00. The current price Teladoc Health (TDOC) is trading at is $8.37, which is out of the analyst’s predicted range.